UK | pharmaphorum

UK

News

Novartis' Pluvicto gets first European approval in GB

Novartis has secured its first approval in Europe for prostate cancer radioligand therapy Pluvicto, getting a green light from the UK Medicines and Healthcare products Regulatory Agency (MH

News

COVID antibody declines prompts call for booster jabs ASAP

Figures from the UK Office for National Statistics (ONS) have revealed that the number of people with higher levels of COVID-19 antibodies in their blood is declining quickly – leading to c

News

Report finds UK risks falling behind rivals in life sciences

A just-published report on the UK's life sciences sector "ought to ring alarm bells across government," according to the Association of the British Pharmaceutical Industry (ABPI).<

News

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricin...

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.

News

BMS' Opdivo gets NHS use as adjuvant bladder cancer therapy

NICE has recommended routine use of Bristol-Myers Squibb's Opdivo for the adjuvant treatment of some patients with urothelial carcinoma (UC), the most common form of bladder cancer.

News

UK health secretary Sajid Javid in shock resignation

UK health secretary Sajid Javid is giving up his position after a year in the role, saying in his resignation letter that he can "no longer, in good conscience, continue serving in this gov

Novartis' Pluvicto gets first European approval in GB

COVID antibody declines prompts call for booster jabs ASAP

Report finds UK risks falling behind rivals in life sciences

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricin...

BMS' Opdivo gets NHS use as adjuvant bladder cancer therapy

UK health secretary Sajid Javid in shock resignation

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

UK

Editor's Picks